Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 0.0× sales vs its 1.0× historical median P/S.
Fair value ≈ $2.16 · price $0.05 today
Undervalued · 98% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$MAULCOIN.X $PET $MAULCOIN.X $PET $DOGE.X $WEEDCOIN.X $BUTTCOIN.X
I don’t care what coin you dabble in. Anyone can/should get behind this cause. #Maulingforacause
🚨 $PETV is shaping up to be one of the most interesting microcap pet‑health turnarounds on the market!
🔹Regenerative medicine products for pets & horses
🔹Q2 revenue jumped to ~$303K (+51% YoY)
🔹H1 revenue hit $600K+ (+85% YoY)
🔹Total liabilities slashed ~79%, balance sheet the cleanest it’s been in years
🔹OpEx down, losses improving, distributor revenue up 35% YoY
Why $PETV stands out:
🔸First international expansion underway (UK + Mexico)
🔸10‑year exclusive pet‑focused AI platform deal targeting next‑gen pet owners
🔸Access to 7,000+ vet clinics through strategic partnerships
🔸New biomaterial R&D combining Spryng with tissue/bone regeneration
Still a microcap -- thin liquidity, volatility, and dilution risk remain. But momentum is real: revenue accelerating, costs tightening, and catalysts stacking.
Communicated Disclaimer – https://chartingdaily.com/pet-joint-care
$CHWY $PET $BARK
🚨 $PETV is revolutionizing the $39B Companion Animal Healthcare market!
🔹Flagship Innovation: Spryng with OsteoCushion technology addresses the root cause of joint pain, not just the symptoms, already treated 12,000+ animals.
🔹Market Expansion: Recently secured a breakthrough 10-year AI licensing agreement (AgenticPet) and expanded distribution into the UK and Mexico.
🔹Clinical Validation: Robust IP portfolio with 12+ U.S. patents and positive clinical study data showing 100% improvement in quality of life for treated patients.
Watching for a breakout over $1.22 to confirm the short-term trend reversal.
(9/21 EMA crossover & pivot bottom support at $1.16)
Communicated Disclaimer – https://chartingdaily.com/pet-joint-care
FOR MORE GUIDANCE AND GROWTH POTENTIAL. CLICK ON THE LINK ABOVE FOR OUR RESEARCH.
$CHWY $PET $RPGL $BNAI
$PETS $XRT Good news for debt-free PetMed Express (PETS).
Specifically, Wag Group $PET filed for bankruptcy, so PETS could benefit from PET's bankruptcy, because most of PET's revenue are coming from the wellness segment and the pet food segment of the pet industry: https://www.nasdaq.com/articles/wag-group-co-pursues-pre-packaged-chapter-11-restructuring-strengthen-financial-position
